Menu

Surmodics, Inc. SRDX

Full chart Compare
Set alert

Price alert · SRDX

All alert types
42.98 0.00 (+0.00%)

Nov 25, 2025, 9:30 AM EST

42.98 Day range 42.98

52-week range unavailable

YTD
+8.54%
1 year
+9.50%

Revenue & Expenses

Revenue by
Product → Revenue: $73.59MRevenue → Gross Profit: $93.05MGross Profit → Expenses: $93.05MRevenue → Cost of Revenue: $33.03MExpenses → Selling, General & Admin: $56.84MExpenses → Research & Development: $10.00MExpenses → Other Operating Expenses: $31.86MExpenses → Other Expenses: $1.86MExpenses → Income Tax: $4.04MRoyalties → Revenue: $42.49MNet Loss → Expenses: $11.54MResearch Development And Other → Revenue: $10.00MGross Profit$93.05MNet Loss$11.54MCost of Revenue$33.03MExpenses$104.59MSelling, General & Admin$56.84MResearch & Development$10.00MOther Operating Expenses$31.86MOther Expenses$1.86MIncome Tax$4.04MRevenue$126.08MProduct$73.59MRoyalties$42.49MResearch Development And Other$10.00M

Latest period ending Sep 30, 2024 · select a line to chart its full history

SRDX annual income statement
Fiscal yearFY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021FY 2020 Sep 30, 2020
126.08M132.58M99.95M105.14M94.86M
93.05M107.62M79.61M87.96M79.55M
-5.64M5.15M-22.10M6.70M-1.25M
-11.54M-1.54M-27.27M4.24M1.12M
-0.82-0.11-1.960.300.08
SRDX annual balance sheet
Fiscal yearFY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021FY 2020 Sep 30, 2020
36.12M41.42M19.00M31.15M30.79M
178.56M185.73M158.36M194.59M168.76M
59.66M65.82M49.97M54.51M37.71M
29.55M29.41M10.00M10.00M0
118.90M119.91M108.39M140.09M131.06M
SRDX annual cash flow
Fiscal yearFY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021FY 2020 Sep 30, 2020
248.00K10.51M-17.22M15.39M14.01M
-2.94M-6.82M6.23M-25.24M-9.07M
-2.95M18.41M-375.00K10.23M-4.65M
-3.49M-2.92M-3.37M-5.28M-3.67M
-5.30M22.42M-12.15M368.00K424.00K